![]() ![]() ![]() Natus brands have been setting the standard for patient care for over 85 years. The Natus product portfolio represents a heritage of innovation and leadership. With sales in over 100 countries, Natus is a leader in neurodiagnostics, pediatric retinal imaging, and infant hearing screening, as well as a leading company in hearing assessment, hearing instrument fitting, balance, and intracranial pressure monitoring. The Company offers hardware, advanced software and algorithms, and consumables that provide stimulus, acquire and monitor physiological signals, and capture the body's response. Noll added "the management of our new Natus Neuro Team will work closely with Micromed management to build upon the Micromed momentum in the European Epilepsy market and the emerging presence of Moberg in the ICU."Ībout Natus -Natus delivers innovative and trusted solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and eight sensory nervous systems to advance the standard of care and improve patient outcomes and quality of life. "Joining the forces of the Natus and Micromed teams with their collective knowledge and passion for neurodiagnostics and neurocritical care, will result in both a more comprehensive product offering and an unrivaled global service and support structure for the benefit of our customers," said Austin Noll, Natus President and leader of Natus Neuro. The products will also enable a strong platform for new product development in electroencephalography (EEG), polysomnography (PSG), electromyography (EMG), and intensive care unit (ICU) monitoring through the integration of the best aspects of both product portfolios, including backward compatibility. A Natus legacy of over 85 years of neurodiagnostic leadership including brands such as NeuroWorks ®/SleepWorks ™, Natus Quantum ®, Grass ®, Nicolet ®, Xltek ®, Embla ®, Dantec ™ TECA ® and others will combine with the complete line of Micromed solutions including BRAIN QUICK ®/MYOQUICK ®, NEUROWERK ®, SleepRT ® and MOBERG. Together, Natus and Micromed will provide customers with a best-in-class portfolio of neurodiagnostic and neuromonitoring solutions. "The breadth and depth of clinical expertise in Natus and Micromed will enable us to bring exciting innovation to our neuroscience customers and their patients around the globe," "We are pleased to make this first growth-oriented investment as an ARCHIMED portfolio company," said Thomas J. The acquisition of Micromed will be the first transaction by Natus since being acquired by the ArchiMed Group ("ARCHIMED") in July of this year. The transaction is expected to close in early 2023, subject to the receipt of regulatory approvals. 2, 2022 /CNW/ - Natus Medical Incorporated (the "Company" or "Natus"), a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders, has entered into a definitive agreement to acquire Micromed Holding SAS ("Micromed Group" or "Micromed"), a global provider of neurophysiology solutions. Exciting combination of product solutions will create a leading neurodiagnostic and neuromonitoring portfolio supported by an organization of knowledgeable and passionate experts. ![]()
0 Comments
Leave a Reply. |